Bristol Myers Squibb BMY
NYSE BMY
$63.88 +1.02 (+1.62%)
As of: Sep 28, 2026 · 3:59 PM EDT

Bristol Myers Squibb (BMY) Short-Term Debt repayments (2024)

Updated

Bristol Myers Squibb (BMY) posted Short-Term Debt repayments of $3 billion for FY2024.

Analysis

Bristol Myers Squibb (BMY) Short-Term Debt repayments (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 6.45 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn -
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn -
10 Bristol Myers Squibb 128.45 Bn 79.72 Bn 9.25 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 269.00 Mn
API Access

Bristol Myers Squibb Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=BMY&period=max&api_key=YOUR_API_KEY